In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Taysha Gene Therapies Inc (NASDAQ: TSHA) was $1.63 for the day, up 0.62% from the previous closing price of $1.62. In other words, the price has increased by $0.62 from its previous closing price. On the day, 1.21 million shares were traded. TSHA stock price reached its highest trading level at $1.76 during the session, while it also had its lowest trading level at $1.59.
Ratios:
Our analysis of TSHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.51. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 334057088 and an Enterprise Value of 239387584. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.71 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 24.144 whereas that against EBITDA is -2.949.
Stock Price History:
The Beta on a monthly basis for TSHA is 0.90, which has changed by -0.24186045 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -11.06%, while the 200-Day Moving Average is calculated to be -27.66%.
Shares Statistics:
TSHA traded an average of 3.55M shares per day over the past three months and 2257500 shares per day over the past ten days. A total of 204.94M shares are outstanding, with a floating share count of 156.65M. Insiders hold about 25.07% of the company’s shares, while institutions hold 76.81% stake in the company. Shares short for TSHA as of 1738281600 were 24081792 with a Short Ratio of 6.78, compared to 1735603200 on 25878980. Therefore, it implies a Short% of Shares Outstanding of 24081792 and a Short% of Float of 15.509999999999998.
